IDBS, the leading worldwide provider of research data management and analytics solutions to R&D organizations, announced that its Biomarker Discovery and Validation Solution will be a key component in an $11 million National Heart, Lung and Blood Institute (NHLBI) award to create a molecular roadmap for chronic lung diseases…

Read The Full Article…IDBS Biomarker Discovery And [...] Read more »

Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced that more than 12,000 courses of lung cancer treatment have been completed with CyberKnife radiosurgery. Usage of CyberKnife radiosurgery for lung cancer continues to grow, as illustrated by a 25 percent increase year over year in calendar year 2009…

Read The Full Article…Benefits [...] Read more »

2010: Year of the Lung is a global initiative instituted by the Forum of International Respiratory Societies (FIRS), a collaboration of the world’s leading professional respiratory organizations. 2010: Year of the Lung aims to raise awareness of and advocate for lung health globally and at the country level to reduce lung disease morbidity and mortality.Learn [...] Read more »

Dr Jorg Hartkamp and Dr Stefan Roberts have found that the protease HtrA2 can “clean” cells of the oncogene WT1, which is found at high levels in many leukaemias and solid cancers such as breast and lung cancer. Their work has given drug designers a new target which will allow them to develop treatments for [...] Read more »

YM BioSciences Inc. (NYSE YMI, TSX:YM), announced that the FDA has advised the Company that it may now enroll patients at US clinical sites into two ongoing randomized, double-blind Phase II trials of its lead product, nimotuzumab…

Read The Full Article…YM BioSciences Announces FDA Clearance For Two Ongoing Phase II Nimotuzumab Trials Into USA Read more »

Medical Acoustics LLC, a commercial-stage medical device company which employs acoustic technologies for diagnostic and therapeutic medical applications, today announced that it has received FDA 510(k) clearance of its Therapeutic Lung Flute®…

Read The Full Article…Medical Acoustics Receives FDA 510(k) Clearance Of Therapeutic Lung Flute(R) Read more »

Four scientists at Barrow Neurological Institute at St. Joseph’s Hospital and Medical Center have been awarded more than $2.2 million from the National Institutes of Health (NIH) to research the effects of nicotine and develop new tobacco-related drug therapies. The grants will fund three separate research projects at the Phoenix-based institute in the next several [...] Read more »

Reporting in Nature Cell Biology, researchers describe the discovery of a specific protein called disabled-2 (Dab2) that switches on the process that releases cancer cells from the original tumor and allows the cells to spread and develop into new tumors in other parts of the body…

Read The Full Article…Discovery Of Switch That Turns On The [...] Read more »

The master gene called SRC-3 (steroid receptor coactivator 3) not only enhances estrogen-dependent growth of cancer cells by activating and encouraging the transcription of a genetic message into a protein, it also sends a signal to the cell membrane to promote cell motility or movement – a key element of cancer spread or metastasis, said [...] Read more »

Biological-based therapies such as diet supplements and vitamins are the most popular complementary and alternative medicines for women recovering from breast cancer, according to a Michigan State University researcher working to create a support intervention for women in treatment for the disease…

Read The Full Article…Linking Breast Cancer Patients With Alternative Therapies Read more »